2014
DOI: 10.1016/j.sjopt.2014.06.011
|View full text |Cite
|
Sign up to set email alerts
|

Management strategies for persistent epithelial defects of the cornea

Abstract: Management of patients with persistent epithelial defects of the cornea can be challenging to even the seasoned ophthalmologist. It is essential that one understands not only the pathophysiology of the failure of the epithelium to migrate and close a wound appropriately, but also the mechanism of action of the available treatment modalities at one's disposal. This article serves as a review of current standard therapies, recently introduced alternative therapies gaining in popularity, and a look into the newes… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
86
0
5

Year Published

2015
2015
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 97 publications
(98 citation statements)
references
References 42 publications
0
86
0
5
Order By: Relevance
“…In such cases, the epithelium at the edges of the defect may be removed, effectively enlarging the defect. This triggers the healing response in the surrounding epithelium promoting migration to close the defect (Katzman and Jeng, 2014).…”
Section: Debridementmentioning
confidence: 99%
See 1 more Smart Citation
“…In such cases, the epithelium at the edges of the defect may be removed, effectively enlarging the defect. This triggers the healing response in the surrounding epithelium promoting migration to close the defect (Katzman and Jeng, 2014).…”
Section: Debridementmentioning
confidence: 99%
“…A conjunctival flap is recommended when descemetocele or perforation recurs despite previous corneal transplantation (Vasseneix et al, 2006). The Boston keratoprosthesis implantation has emerged as an effective modality for visual rehabilitation in such patients (Katzman and Jeng, 2014;Pavan-Langston and Dohlman, 2008).…”
Section: Corneal Transplantsmentioning
confidence: 99%
“…UCS may serve as a viable alternative in patients who are not good candidates for ASE therapy, such as those with graft-versus-host disease (GVHD) or SS, where pro-inflammatory cytokines could be present in the serum 63. UCS has potential applications in the treatment of PEDs,33 GVHD-associated dry eye,18 SS-type DES,19 recurrent corneal erosions35 and chemical burns 37 38.…”
Section: Umbilical Cord Serummentioning
confidence: 99%
“…These defects are usually treated with lubricants, punctal occlusion, pressure patching, debridement of the epithelial defect and tarsorrhaphy of the eyelids. 39 A temporary ptosis by means of injecting Botulinum toxin into the upper eyelid may also be considered. These defects may also be covered with a bandage soft contact lens which aids the regeneration process by protecting the advancing epithelium from being sloughed off.…”
Section: The Benefit Of Ex Vivo Transplantation Of Limbal Stem Cellsmentioning
confidence: 99%